# Treatment for Cognitive Impairment in Depression

> **NCT04317001** · PHASE3 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Modafinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04317001
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-12-01
- **Primary completion:** 2022-11-30
- **Final completion:** 2024-11-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Researcher leading the study moved institutions study not feasible
- **Last updated:** 2020-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04317001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04317001, "Treatment for Cognitive Impairment in Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04317001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*